Gestational Choriocarcinoma With Inferior Vena Cava Tumor Thrombus Formation.

J Obstet Gynaecol ResOct 1, 2026

Qiong Yang, Ziyan Liang, Zhenhua Ming et al.

✦ AI-curated · Sources linked

Case in brief

A 52-year-old woman presented with recurrent nausea and vomiting, leading to the discovery of elevated serum β-hCG levels and a pelvic mass extending into the inferior vena cava (IVC). Biopsy confirmed gestational choriocarcinoma. The patient also had pulmonary hypertension and emboli. Following EMA-CO chemotherapy, she achieved complete remission with no recurrence at one-year follow-up.

What made this case unusual

The presence of an inferior vena cava tumor thrombus in conjunction with gestational choriocarcinoma is exceedingly rare and presents significant diagnostic challenges.

Diagnostic / clinical pearl

Clinicians should consider gestational choriocarcinoma in women with a history of pregnancy presenting with unexplained systemic symptoms, especially when elevated β-hCG levels are noted.

Why it matters

This case emphasizes the need for awareness of non-classical metastases in choriocarcinoma, which can complicate diagnosis and management.

Source

Published in J Obstet Gynaecol Res. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Oncology (Medical)

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.